News and Announcements
Article highlight
World-First FDA Approval for EBR Systems’ Leadless Cardiac Device Opens US$3.6bn Market
Published 22.04.25
Discover how EBR Systems’ groundbreaking WISE CRT System, the first leadless left ventricular pacing technology, has gained FDA approval, addressing limitations of traditional cardiac resynchronisation therapy.
Capital Insights
Half a Century in Bricks and Mortar: Industry Veteran Greg Paramor on Revealing Real Estate Opportunities in a Shifting Landscape
Read more
Freelancer.com: Building the Amazon of Services and Beyond
Read more
Beyond the Balance Sheet: Decoding the DNA of Family Office Investing
Read more
Larry Fink Signals a New Era of Wealth Creation Focused on Private Markets
Read more
Executive Interviews
Capital Insights
Company Updates
Venture Investor Interviews
Backed By Leading Investment Groups and Family Offices



